BMS Pharmaceutical's Baraclude 0.5mg recorded no.1 in import of drug product last year
According to Korea Pharmaceutical Traders Association, BMS Pharmaceutical's Baraclude 0.5mg recorded no.1 in import of drug product last year.
Baraclude 0.5mg recorded import of $ 8.183 million, followed by MSD's Gadacil $ 5.943 million, Pfizer Korea's pneumococcal vaccine Prevenar $ 4.929 millo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
